Clinical Trial Update: Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial updating on aspirin's impact on platelet reactivity in acute coronary syndrome patients receiving novel P2Y12 inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Sheba Medical Center | Conditions: Acute Coronary Syndrome, Platelet Function and Reactivity Tests | Phase 4 | Status: COMPLETED